Vivo Biosciences, Inc.

1601 12th Avenue South,
Birmingham, Alabama 35205
United States,
(205) 930-0001

Vivo Biosciences, Inc. is a developer of a patented "all-human" bioassay platform, HuBiogel, which allows for rapid analysis of drug efficacy, toxicity and therapy prediction in the preclinical research, drug discovery and therapeutics markets.

Vivo Biosciences was acquired by LifeNet Health on November 02, 2016.

Join Mergr to view all 274 acquisitions of life science companies in 2016, including 23 acquisitions by private equity firms, and 251 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Vivo Biosciences.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.